297 related articles for article (PubMed ID: 8808731)
21. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.
Nikkhah G; Cunningham MG; Jödicke A; Knappe U; Björklund A
Brain Res; 1994 Jan; 633(1-2):133-43. PubMed ID: 7907929
[TBL] [Abstract][Full Text] [Related]
22. Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.
Drandarevski N; Marburger A; Walther D; Reum T; Uh G; Morgenstern R
J Neural Transm (Vienna); 2001; 108(2):141-51. PubMed ID: 11314769
[TBL] [Abstract][Full Text] [Related]
23. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
[TBL] [Abstract][Full Text] [Related]
24. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
[TBL] [Abstract][Full Text] [Related]
25. Development of intrastriatal striatal grafts and their afferent innervation from the host.
Labandeira-Garcia JL; Wictorin K; Cunningham ET; Björklund A
Neuroscience; 1991; 42(2):407-26. PubMed ID: 1716746
[TBL] [Abstract][Full Text] [Related]
26. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys.
Emborg ME; Ma SY; Mufson EJ; Levey AI; Taylor MD; Brown WD; Holden JE; Kordower JH
J Comp Neurol; 1998 Nov; 401(2):253-65. PubMed ID: 9822152
[TBL] [Abstract][Full Text] [Related]
27. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells.
Vuillet J; Moukhles H; Nieoullon A; Daszuta A
Exp Brain Res; 1994; 98(1):84-96. PubMed ID: 7912201
[TBL] [Abstract][Full Text] [Related]
29. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
[TBL] [Abstract][Full Text] [Related]
30. Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age.
Annett LE; Torres EM; Clarke DJ; Ishida Y; Barker RA; Ridley RM; Baker HF; Dunnett SB
Cell Transplant; 1997; 6(6):557-69. PubMed ID: 9440865
[TBL] [Abstract][Full Text] [Related]
31. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum.
Bolam JP; Freund TF; Björklund A; Dunnett SB; Smith AD
Exp Brain Res; 1987; 68(1):131-46. PubMed ID: 2446902
[TBL] [Abstract][Full Text] [Related]
32. Fetal nigral transplantation as a therapy for Parkinson's disease.
Olanow CW; Kordower JH; Freeman TB
Trends Neurosci; 1996 Mar; 19(3):102-9. PubMed ID: 9054056
[TBL] [Abstract][Full Text] [Related]
33. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
Kordower JH; Goetz CG; Chu Y; Halliday GM; Nicholson DA; Musial TF; Marmion DJ; Stoessl AJ; Sossi V; Freeman TB; Olanow CW
Ann Neurol; 2017 Jan; 81(1):46-57. PubMed ID: 27900791
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
[TBL] [Abstract][Full Text] [Related]
35. Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants.
Zhou J; Bradford HF; Stern GM
Brain Res Dev Brain Res; 1997 May; 100(1):43-51. PubMed ID: 9174245
[TBL] [Abstract][Full Text] [Related]
36. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis.
Costantini LC; Vozza BM; Snyder-Keller AM
Exp Neurol; 1994 Jun; 127(2):219-31. PubMed ID: 7913445
[TBL] [Abstract][Full Text] [Related]
37. Ageing changes in the transplants of fetal substantia nigra grafted to striatum of adult rat.
Gopinath G; Shetty AK; Tandon PN
Neuroscience; 1991; 40(2):429-43. PubMed ID: 1674112
[TBL] [Abstract][Full Text] [Related]
38. Axonal sprouting following lesions of the rat substantia nigra.
Finkelstein DI; Stanic D; Parish CL; Tomas D; Dickson K; Horne MK
Neuroscience; 2000; 97(1):99-112. PubMed ID: 10877666
[TBL] [Abstract][Full Text] [Related]
39. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
40. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
Bartlett LE; Mendez I
Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
